Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The 12 mg dose escalation group achieved a 2.02% reduction in HbA1c at 24 weeks, along with 16.94% body weight loss at 36 weeks
AAA1761809 Supplier Thermo Scientific Chemicals Supplier No
220.00 In stock Peptide science is expanding rapidly across many domains of biology
ErenYDirikENeelioluSErel
AstraZeneca has deliberately chosen not to directly compete in the GLP-1/GIP receptor agonist space a strategic choice that, while differentiating, leaves it without exposure to the highest-growth peptide market segment (65.8% of the peptide therapy market
US$ 23.07
US$ 23.41
US$ 22.65
US$ 26.20
